Michael Moussouttas

Summary

Country: USA

Publications

  1. ncbi Prevalence, timing, risk factors, and mechanisms of anterior cerebral artery infarctions following subarachnoid hemorrhage
    Michael Moussouttas
    Cerebrovascular and Critical Care Division, Department of Neurology, Thomas Jefferson University Medical Center, 900 Walnut Street, Suite 200, Philadelphia, PA 19107, USA
    J Neurol 260:21-9. 2013
  2. ncbi Cerebrospinal fluid catecholamine levels as predictors of outcome in subarachnoid hemorrhage
    Michael Moussouttas
    Cerebrovascular and Neurocritical Care Division, Thomas Jefferson Medical Center, Philadelphia, PA, USA
    Cerebrovasc Dis 33:173-81. 2012
  3. ncbi Determinants of central sympathetic activation in spontaneous primary subarachnoid hemorrhage
    Michael Moussouttas
    Cerebrovascular and Neurocritical Care Division, Department of Neurology, Thomas Jefferson Medical Center, 900 Walnut Street, Suite 200, Philadelphia, PA 19107, USA
    Neurocrit Care 16:381-8. 2012
  4. ncbi Role of antiplatelet agents in hematoma expansion during the acute period of intracerebral hemorrhage
    Michael Moussouttas
    Division of Cerebrovascular and Critical Care Neurology, Thomas Jefferson Medical Center, 900 Walnut Street, Suite 200, Philadelphia, PA 19107, USA
    Neurocrit Care 12:24-9. 2010
  5. ncbi Cerebrovascular disease among patients from the Indian subcontinent
    M Moussouttas
    Department of Neurology, NJ Neuroscience Institute, Seton Hall University, South Orange, NJ, USA
    Neurology 67:894-6. 2006
  6. ncbi Eclamptic subarachnoid haemorrhage without hypertension
    Michael Moussouttas
    NJ Neuroscience Institute, JFK Medical Center, Edison, New Jersey 08818, USA
    J Clin Neurosci 13:474-6. 2006
  7. ncbi Pulmonary arteriovenous malformations: cerebral ischemia and neurologic manifestations
    M Moussouttas
    Department of Neurology, Yale University School of Medicine, New Haven, CT 06520, USA
    Neurology 55:959-64. 2000
  8. ncbi Fulminant acute inflammatory demyelinating polyradiculoneuropathy: case report and literature review
    Michael Moussouttas
    Department of Neurology, New York Medical College, USA
    Neurocrit Care 1:469-73. 2004
  9. ncbi Amnestic syndrome of the subcallosal artery: a novel infarct syndrome
    Michael Moussouttas
    New Jersey Neuroscience Institute, JFK Medical Center, Seton Hall University, Edison, NJ, USA
    Cerebrovasc Dis 19:410-4. 2005
  10. ncbi Combination antiplatelet agents in ischemic cerebrovascular disease
    Michael Moussouttas
    Cerebrovascular Division, Department of Neurology, Seton Hall University, South Orange, NJ, USA
    Mt Sinai J Med 72:16-22. 2005

Detail Information

Publications20

  1. ncbi Prevalence, timing, risk factors, and mechanisms of anterior cerebral artery infarctions following subarachnoid hemorrhage
    Michael Moussouttas
    Cerebrovascular and Critical Care Division, Department of Neurology, Thomas Jefferson University Medical Center, 900 Walnut Street, Suite 200, Philadelphia, PA 19107, USA
    J Neurol 260:21-9. 2013
    ..046) again predicted PI. Clinical severity/grade and ACA/ACom aneurysm location are the most consistent predictors of ACA infarctions. Vasospastic and non-vasospastic processes may concurrently contribute to ACA infarcts...
  2. ncbi Cerebrospinal fluid catecholamine levels as predictors of outcome in subarachnoid hemorrhage
    Michael Moussouttas
    Cerebrovascular and Neurocritical Care Division, Thomas Jefferson Medical Center, Philadelphia, PA, USA
    Cerebrovasc Dis 33:173-81. 2012
    ..The purpose of this study is to determine whether early central catecholamine levels measured from cerebrospinal fluid (CSF) relate to outcome in patients with SAH...
  3. ncbi Determinants of central sympathetic activation in spontaneous primary subarachnoid hemorrhage
    Michael Moussouttas
    Cerebrovascular and Neurocritical Care Division, Department of Neurology, Thomas Jefferson Medical Center, 900 Walnut Street, Suite 200, Philadelphia, PA 19107, USA
    Neurocrit Care 16:381-8. 2012
    ..The purpose of this investigation is to identify demographic, clinical, radiological, and anatomical features of SAH that relate to sympathetic activation...
  4. ncbi Role of antiplatelet agents in hematoma expansion during the acute period of intracerebral hemorrhage
    Michael Moussouttas
    Division of Cerebrovascular and Critical Care Neurology, Thomas Jefferson Medical Center, 900 Walnut Street, Suite 200, Philadelphia, PA 19107, USA
    Neurocrit Care 12:24-9. 2010
    ..The purpose of this study was to determine whether the reported use of antiplatelet agents also results in greater hematoma expansion...
  5. ncbi Cerebrovascular disease among patients from the Indian subcontinent
    M Moussouttas
    Department of Neurology, NJ Neuroscience Institute, Seton Hall University, South Orange, NJ, USA
    Neurology 67:894-6. 2006
    ..SA patients experienced a 75% lower risk of cardiogenic infarctions, but a threefold increased risk of intracranial atherothrombosis. Risk factor modifications and secondary prevention strategies may differ for SA patients...
  6. ncbi Eclamptic subarachnoid haemorrhage without hypertension
    Michael Moussouttas
    NJ Neuroscience Institute, JFK Medical Center, Edison, New Jersey 08818, USA
    J Clin Neurosci 13:474-6. 2006
    ..Treatment consisted only of nimodipine for the prevention of vasospasm. The patient made an excellent recovery, without residual neurological deficits...
  7. ncbi Pulmonary arteriovenous malformations: cerebral ischemia and neurologic manifestations
    M Moussouttas
    Department of Neurology, Yale University School of Medicine, New Haven, CT 06520, USA
    Neurology 55:959-64. 2000
    ..PAVM occur in 20 to 30% of the hereditary hemorrhagic telangiectasia (HHT) population...
  8. ncbi Fulminant acute inflammatory demyelinating polyradiculoneuropathy: case report and literature review
    Michael Moussouttas
    Department of Neurology, New York Medical College, USA
    Neurocrit Care 1:469-73. 2004
    ..Fulminant cases of total body paralysis with loss of all cranial nerve reflexes have been described, whereby patients appear to have lost all central nervous system (CNS) function...
  9. ncbi Amnestic syndrome of the subcallosal artery: a novel infarct syndrome
    Michael Moussouttas
    New Jersey Neuroscience Institute, JFK Medical Center, Seton Hall University, Edison, NJ, USA
    Cerebrovasc Dis 19:410-4. 2005
  10. ncbi Combination antiplatelet agents in ischemic cerebrovascular disease
    Michael Moussouttas
    Cerebrovascular Division, Department of Neurology, Seton Hall University, South Orange, NJ, USA
    Mt Sinai J Med 72:16-22. 2005
    ..Combination therapy with aspirin and clopidogrel seems to increase the risk of major hemorrhages, whereas aspirin plus xrDP does not. Ongoing trials are expected to clarify the role of various combination antiplatelet regimens...
  11. ncbi Cannabis use and cerebrovascular disease
    Michael Moussouttas
    Department of Neurology, New York Medical College, Valhalla, NY, USA
    Neurologist 10:47-53. 2004
    ..However, cases of acute onset neurologic dysfunction occurring in relation to cannabis use have been described and corresponding cerebral imaging studies have documented focal ischemic changes and vessel abnormalities...
  12. ncbi Intravascular lymphomatosis presenting as posterior leukoencephalopathy
    Michael Moussouttas
    Department of Neurology, New York Medical College, Valhalla, NY, 10595 USA
    Arch Neurol 59:640-1. 2002
  13. ncbi Impact of intraventricular hemorrhage upon intracerebral hematoma expansion
    Michael Moussouttas
    Division of Cerebrovascular and Neurocritical Care, Thomas Jefferson Medical Center, Philadelphia, PA 19107, USA
    Neurocrit Care 14:50-4. 2011
    ..The purpose of this study is to determine whether intraventricular hemorrhage (IVH) exerts a "decompressive" effect that limits intracerebral hemorrhage (ICH) enlargement...
  14. ncbi CSF catecholamine profile in subarachnoid hemorrhage patients with neurogenic cardiomyopathy
    Michael Moussouttas
    Cerebrovascular and Neurocritical Care Division, Thomas Jefferson Medical Center, 900 Walnut Street, Suite 200, Philadelphia, PA 19107, USA
    Neurocrit Care 14:401-6. 2011
    ..The purpose of this research is to determine whether cerebrospinal fluid (CSF) catecholamine levels are elevated in subarachnoid hemorrhage (SAH) patients with NC when compared to those without NC...
  15. ncbi Thunderclap headache with normal CT and lumbar puncture: further investigations are unnecessary: against
    Michael Moussouttas
    Department of Neurology, Thomas Jefferson University Hospital, Philadelphia, PA, USA
    Stroke 39:1394-5. 2008
  16. ncbi Impact of acute lung injury and acute respiratory distress syndrome after traumatic brain injury in the United States
    Fred Rincon
    Department of Neurology, Division of Critical Care, Thomas Jefferson University, Jefferson College of Medicine, Philadelphia, Pennsylvania 19107, USA
    Neurosurgery 71:795-803. 2012
    ..Traumatic brain injury (TBI) is a major cause of disability, morbidity, and mortality. The effect of the acute respiratory distress syndrome and acute lung injury (ARDS/ALI) on in-hospital mortality after TBI remains controversial...
  17. ncbi Perioperative stroke after total joint arthroplasty: prevalence, predictors, and outcome
    S M Javad Mortazavi
    Rothman Institute of Orthopedics, Thomas Jefferson University Hospital, 925 Chestnut Street, Philadelphia, PA 19107, USA
    J Bone Joint Surg Am 92:2095-101. 2010
    ..In addition, risk factors for the development of this complication were evaluated in an attempt to identify a strategy that could minimize the prevalence of this complication...
  18. ncbi Metabolic syndrome: contributing factors and treatment strategies
    Susan B Fowler
    University of Medicine and Dentistry of New Jersey School of Nursing, The University Hospital, Newark, NJ, USA
    J Neurosci Nurs 37:220-3. 2005
    ....
  19. ncbi Emerging therapies: clopidogrel and aspirin
    Michael Moussouttas
    Stroke 36:707. 2005
  20. ncbi Emerging therapies: ESPRIT
    Michael Moussouttas
    Stroke 38:1142. 2007